Emcure Pharmaceuticals Announces Re-appointment of Independent Directors
Emcure Pharmaceuticals Limited announced the re-appointment of three Independent Directors following a postal ballot concluded on March 20, 2026. The results of the postal ballot were announced on March 24, 2026, based on a report from the Scrutinizer dated March 23, 2026.Mr. Vijay Keshav Gokhale (DIN: 09134089) has been re-appointed for a second term of 5 years, effective April 16, 2026. Dr. Vidya Rajiv Yeravdekar (DIN: 02183179) will serve another 3-year term, also beginning April 16, 2026. Dr. Shailesh Kripalu Ayyangar (DIN: 00268076) has been re-appointed for a second term of 5 years, effective June 02, 2026.
The newly appointed directors are not debarred from holding office by any Securities and Exchange Board of India (SEBI) order and are not related to any other directors or Key Managerial Personnel of the company. Details regarding the appointments are available in a disclosure filed with the National Stock Exchange of India Limited and the BSE Limited.
Amruta Yangalwar, Company Secretary & Compliance Officer (Membership Number: A25687), made the announcement.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.